Metabolomics—the small molecule chemical footprint of biological processes—is poised to take its rightful place beside genomics and proteomics as an enabling bio-technique. Scientists involved in the discovery and clinical development of new drugs should attend this free webinar, Metabolomics: Analytics, Tools, and Applications, to find out more about how this technique can advance cancer and diabetes research.

Those who will benefit from attending this webinar include:

* Biologists who are interested in the metabolic profile of a cell or system * Scientists working in drug discovery and development * Investigators already involved in metabolomics who are interested in learning the latest instrumental techniques * Researchers looking for new techniques for analyzing individual and groups of small molecules of biological interest * Chromatographers and analytical scientists working with small molecule metabolites

Key learning points for this webinar:

* Introduction to and definition of metabolomics * Examples of metabolomes and where they fit into the larger biological picture * Analytical techniques for uncovering and exploiting metabolomics—capabilities and limitations * Implications of metabolomics for biomedicine, drug discovery, and development * Metabolomics case studies in diabetes and prostate cancer

Because the metabolome is reflected in small molecules typically generated in low abundance and with a wide dynamic range, analytical science has been scrambling to devise methods for meeting the metabolomic challenge. Two techniques in particular—gas chromatography and high-performance liquid chromatography—in tandem with mass spectrometry have become the de facto platforms for analyzing the metabolome.

Your hosts for this webinar, Steven Fischer, Ph.D. (Agilent Technologies), Chris Beecher, Ph.D. (University of Michigan), and Chris Newgard, Ph.D. (Duke University), bring years of combined experience surrounding metabolomics. They will present specific examples of how metabolomics can be applied to translational medicine, diabetes, and prostate cancer. A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.REGISTER TODAY www.genengnews.com/metabolomics